FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode

PMA: P080006 · Supplement: S147 · Decision Jul 15, 2020
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
Trade Name
Attain Ability Lead, Attain Performa Lead, Attain Stability Quad MRI Lead
PMA Number
P080006
Supplement Number
S147
Device Class
FDA Class 3
Product Code
OJX
Generic Name
Drug eluting permanent left ventricular (lv) pacemaker electrode
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
July 15, 2020
Date Received
April 27, 2020
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for minor design specification changes for selected implantable leads.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OJX Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode